Leading this effort was Cytel’s principal research scientist and Professor of Health Research Methods at McMaster University in Canada, Dr. Edward Mills
Globally, cervical cancer is the fourth most common cancer among women, with approximately 30,447 new cases diagnosed in Europe in 2020
Children 5 through 11 years of age are now authorized to receive a booster dose at least five months after the second dose of the two-dose primary series
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
The production suspension impacts commercial and clinical trial supply
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
In addition, common light chain antibodies generated by RenLite mice can greatly improve the efficiency of downstream assembly of complex drug molecules such as bispecific antibodies and bispecific antibody-drug conjugates (bsADCs)
The DalPhos ligands were developed by Prof. Mark Stradiotto and his research team at the Department of Chemistry, Dalhousie University
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
Subscribe To Our Newsletter & Stay Updated
